MS Clinical Trials

Clinical Trials on new therapies for MS based at the National Hospital for Neurology and Neurosurgery (NHNN) and the Leonard Wolfson Experimental Neurology Centre (LWENC) in Queen Square:

• Octopus: a new trial for progressive MS
• MS-STAT2 
• Alexander Disease Trial
• NMR Research Unit Trials Office

New Clinical Trials that are based in other London Hospitals, with MRI carried out in the Queen Square Multiple Sclerosis Centre:

AttackMS: A new Clinical Trial that is based in other London Hospitals, with MRI carried out in the Queen Square Multiple Sclerosis Centre. This trial is on Natalizumab for treatment of inflammatory demyelination suggestive of MS, or definite MS, at first presentation.

• Detailed information on AttackMS

  Detailed information on AttackMS
• Video: AttackMS: assessing the feasibility of multiple sclerosis treatment within 14 days of presentation.
• Video: Why has the AttackMS trial been suggested to me? Some patients explain more.

ChariotMS:  This is a new multi-centre (20 sites across the U.K) trial of cladribine in patients with advanced MS.

• Detailed information on ChariotMS

  Detailed information on ChariotMS
• Video: ChariotMS: the first DMT trial in advanced multiple sclerosis.

CLOSED TRIAL: MS-SMART: MS-Secondary Progressive Multi-Arm Randomisation Trial.

Page updated 09-05-2023.